Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$235K	Hold	3,140	–	–	0.11%	59
2023 Q2	$240K	Sell	3,140 -23	-0.7%	-$1.83K	0.1%	62
2023 Q1	$261K	Buy	3,163 +23	+0.7%	+$1.91K	0.12%	57
2022 Q4	$270K	Buy	+3,140	New	+$249K	0.14%	53
2022 Q1	–	Sell	-3,140	Closed	-$228K	–	74
2021 Q4	$228K	Hold	3,140	–	–	0.08%	63
2021 Q3	$212K	Hold	3,140	–	–	0.08%	68
2021 Q2	$220K	Hold	3,140	–	–	0.08%	68
2021 Q1	$208K	Buy	+3,140	New	+$202K	0.08%	70
2020 Q4	–	Sell	-1,855	Closed	-$117K	–	86
2020 Q3	$117K	Sell	1,855 -1,240	-40%	-$86K	0.05%	71
2020 Q2	$238K	Hold	3,095	–	–	0.13%	59
2020 Q1	$237K	Buy	+3,095	New	+$214K	0.16%	53

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Wealth Advisors's GILD Position: Q3 2023 in Review

Wealth Advisors held its Gilead Sciences (GILD) position steady in Q3 2023 at 3,140 shares worth $235K. The position accounts for 0.11% of the portfolio, ranked #59.

Wealth Advisors first reported a position in GILD in Q1 2020 and has held it in 11 quarters since. The position peaked at $270K in Q4 2022. 1,681 funds tracked by Wall St. Rank hold GILD as of Q3 2023.

Wealth Advisors held 3,140 shares of Gilead Sciences worth $235K as of Q3 2023.
Wealth Advisors left its Gilead Sciences share count unchanged in Q3 2023.
Gilead Sciences made up 0.11% of Wealth Advisors's portfolio in Q3 2023, its #59 holding.
Wealth Advisors first reported a position in Gilead Sciences in Q1 2020 and has held it in 11 quarters since.
Wealth Advisors's Gilead Sciences position peaked at $270K in Q4 2022.
1,681 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2023.

Based on Wealth Advisors's 13F filing for Q3 2023, filed 24 Oct 2023.